financetom
Business
financetom
/
Business
/
Market Chatter: Nvidia Says 15% US Commission on China Chip Sales Still Unclear
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Nvidia Says 15% US Commission on China Chip Sales Still Unclear
Aug 28, 2025 3:59 AM

06:30 AM EDT, 08/28/2025 (MT Newswires) -- Nvidia ( NVDA ) said a proposed Trump administration plan to impose a 15% commission on its AI chip sales to China remains in early discussions and lacks any formal regulatory framework, Bloomberg reported Thursday.

According to the report, the company said late Wednesday that the US government has not provided details on how such a fee would be enforced.

Chief Financial Officer Colette Kress told Bloomberg that if the plan isn't officially implemented, Nvidia ( NVDA ) expects to continue selling to China under existing licenses without paying the commission.

The White House and Commerce Department did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-One Liberty Properties To Acquire An Industrial Building For $33 Mln
BRIEF-One Liberty Properties To Acquire An Industrial Building For $33 Mln
Jun 24, 2024
June 24 (Reuters) - One Liberty Properties Inc ( OLP ): * ONE LIBERTY PROPERTIES ( OLP ): TO ACQUIRE AN INDUSTRIAL BUILDING FOR $33 MILLION Source text for Eikon: Further company coverage: ...
Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise
Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise
Jun 24, 2024
10:30 AM EDT, 06/24/2024 (MT Newswires) -- Rani Therapeutics ( RANI ) said Monday it signed a deal with ProGen for the co-development and commercialization of the RT-114 oral RaniPill capsule containing ProGen's PG-102 to treat obesity. The companies will share responsibilities for the development and commercialization of RT-114 globally, including a 50/50 cost and revenue-share arrangement, Rani said. Rani...
Rail Vision Gets Japanese Patent for AI Railway Obstacle Detection System
Rail Vision Gets Japanese Patent for AI Railway Obstacle Detection System
Jun 24, 2024
10:30 AM EDT, 06/24/2024 (MT Newswires) -- Rail Vision ( RVSN ) said Monday it has received a notice of allowance from the Japan Patent Office for its artificial intelligence-based railway obstacle detection system. The patent's features include improved safety measures to reduce collision risks and AI-driven image processing to identify the railway path and detect potential obstacles, the company...
Revelation Biosciences Shares Jump on Positive Results for Investigational Drug Gemini
Revelation Biosciences Shares Jump on Positive Results for Investigational Drug Gemini
Jun 24, 2024
10:25 AM EDT, 06/24/2024 (MT Newswires) -- Revelation Biosciences' ( REVB ) shares surged 33% in recent trading Monday after the company announced its investigational drug Gemini met the primary endpoint of safety and tolerability of escalating doses in healthy volunteers during a phase 1 study in Australia. The company is developing Gemini as a potential pretreatment to prevent or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved